Inhibrx Biosciences Inc.
13.49
0.75 (5.89%)
At close: Jan 15, 2025, 3:59 PM
13.47
-0.15%
After-hours Jan 15, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -239.73M -145.23M -81.77M -76.12M -51.40M -31.02M -22.08M -8.27M
Depreciation & Amortization 1.19M 1.23M 1.20M 1.02M 1.16M 676.00K 399.00K 253.00K
Stock-Based Compensation 24.85M 17.79M 15.05M 5.02M 3.97M 2.48M 1.18M 552.00K
Other Working Capital 13.76M 3.74M -1.67M -5.61M 8.94M 556.00K -556.00K -6.35M
Other Non-Cash Items 5.03M 5.09M 2.73M 11.56M 9.61M 522.00K 746.00K -3.37M
Deferred Income Tax n/a n/a -9.00K -2.14M 1.08M n/a n/a n/a
Change in Working Capital 15.35M 3.16M -17.52M 12.69M 3.48M 4.25M 999.00K -6.28M
Operating Cash Flow -193.31M -115.30M -80.32M -47.97M -32.08M -23.09M -18.75M -18.11M
Capital Expenditures -4.59M -686.00K -864.00K -1.36M -1.81M -1.43M -1.34M -215.00K
Acquisitions n/a n/a 55.00K n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a 55.00K n/a n/a n/a n/a n/a
Investing Cash Flow -4.59M -686.00K -809.00K -1.36M -1.81M -1.43M -1.34M -215.00K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a -828.00K -1.38M n/a
Other Financial Acitivies 201.96M 128.81M 83.77M 166.46M 43.33M 13.98M 14.91M 28.77M
Financial Cash Flow 201.96M 258.55M 83.77M 166.46M 43.33M 13.15M 13.54M 28.77M
Net Cash Flow 4.06M 142.56M 2.64M 117.12M 9.44M -11.37M -6.55M 10.45M
Free Cash Flow -197.90M -115.99M -81.19M -49.33M -33.89M -24.52M -20.09M -18.32M

Create Price Alert on INBX

Your price alert will notify you when the stock price is above 13.49.

Add to Watchlist